ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS
The outcome of adults and children with Acute Promyelocytic Leukemia (APL) has dramatically changed since the introduction of all trans retinoic acid (ATRA) therapy. Based on the results of several multicenter trials, the current recommendations for the treatment of patients with APL include ATRA an...
Main Authors: | Anna Maria Testi, Francesco Lococo |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2014-04-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/1368 |
Similar Items
-
Acute promyelocytic leukemia presenting as pulmonary thromboembolism: Not all APLs bleed
by: Ashok K Vaid, et al.
Published: (2015-10-01) -
Acute Promyelocytic Leukemia (APL) Relapsing into AML-M2 with Normal Cytogenetics. A report.
by: Ranjit Kumar Sahoo, et al.
Published: (2014-08-01) -
Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity
by: Tâmara Dauare de Almeida, et al.
Published: (2023-02-01) -
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group
by: Dan-Ping Huang, et al.
Published: (2023-12-01) -
Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3
by: Ji-Hea Kim, et al.
Published: (2022-08-01)